A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Д. А. Шапиро, Mitchell L. Shiffman et al.|New England Journal of Medicine|2016Cited by 1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Velimir A. Luketic, Juan F. Gallegos‐Orozco et al.|Gastroenterology|2016Cited by 1k
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant RecipientsJames Neuberger, Teun van Gelder, Wolf O. Bechstein et al.|Transplantation|2017Cited by 309
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failureWim Laleman, Frederik Nevens, Alexander Wilmer et al.|Critical Care|2006Cited by 249
New findings in HCV genotype distribution in selected West European, Russian and Israeli regionsVladimir Kartashev, Orna Mor, Matthias Döring et al.|Journal of Clinical Virology|2016Cited by 73